RIGL vs SJM · P/E 9.1, rev $137.5M vs rev $9.05B
Rigel Pharmaceuticals Inc (RIGL) versus JM Smucker Company (SJM) — a side-by-side from cached financials, not a winner call.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
JM Smucker Company (SJM) is a packaged foods company listed on US.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Latest reported SJM revenue for 2026-04-30 was $9.05B. Net income was -$138.7M. Revenue was up 3.7% from 2025-04-30 to 2026-04-30. SJM currently screens at market cap $11.10B.
RIGL currently screens at market cap $338.3M and trailing P/E 9.1. SJM currently screens at market cap $11.10B.
Not investment advice. Open the RIGL and SJM stock pages for the full models.
Not investment advice.